These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24174221)

  • 1. Long-term experience with reduced planning target volume margins and intensity-modulated radiotherapy with daily image-guidance for head and neck cancer.
    Chen AM; Yu Y; Daly ME; Farwell DG; Benedict SH; Purdy JA
    Head Neck; 2014 Dec; 36(12):1766-72. PubMed ID: 24174221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the planning target volume in the treatment of head and neck cancer with intensity-modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance?
    Chen AM; Farwell DG; Luu Q; Donald PJ; Perks J; Purdy JA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):943-9. PubMed ID: 20932680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning.
    Chen AM; Daly ME; Cui J; Mathai M; Benedict S; Purdy JA
    Head Neck; 2014 Nov; 36(11):1541-6. PubMed ID: 23996502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of failure after intensity-modulated radiotherapy in head and neck squamous cell carcinoma using compartmental clinical target volume delineation.
    Bayman E; Prestwich RJ; Speight R; Aspin L; Garratt L; Wilson S; Dyker KE; Sen M
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):636-42. PubMed ID: 24928558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.
    Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R
    Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and topographic characterization of locoregional recurrences in head and neck tumours.
    Ferreira BC; Marques RV; Khouri L; Santos T; Sá-Couto P; do Carmo Lopes M
    Radiat Oncol; 2015 Feb; 10():41. PubMed ID: 25889988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT).
    Navran A; Heemsbergen W; Janssen T; Hamming-Vrieze O; Jonker M; Zuur C; Verheij M; Remeijer P; Sonke JJ; van den Brekel M; Al-Mamgani A
    Radiother Oncol; 2019 Jan; 130():25-31. PubMed ID: 30005953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image Guidance-Based Target Volume Margin Expansion in IMRT of Head and Neck Cancer.
    Srivastava SP; Cheng CW; Das IJ
    Technol Cancer Res Treat; 2016 Feb; 15(1):107-13. PubMed ID: 25432930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of interfraction patient setup for head-and-neck cancer intensity modulated radiation therapy using multiple computed tomography-based image guidance.
    Qi XS; Hu AY; Lee SP; Lee P; DeMarco J; Li XA; Steinberg ML; Kupelian P; Low D
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):432-9. PubMed ID: 23474111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of
    Berwouts D; Madani I; Duprez F; Olteanu AL; Vercauteren T; Boterberg T; Deron P; Bonte K; Huvenne W; De Neve W; Goethals I
    Head Neck; 2017 Nov; 39(11):2264-2275. PubMed ID: 28833829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial clinical experience with helical tomotherapy for head and neck cancer.
    Chen AM; Jennelle RL; Sreeraman R; Yang CC; Liu T; Vijayakumar S; Purdy JA
    Head Neck; 2009 Dec; 31(12):1571-8. PubMed ID: 19405087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.
    Chen AM; Farwell DG; Luu Q; Chen LM; Vijayakumar S; Purdy JA
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1423-9. PubMed ID: 20656416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
    Dirix P; Nuyts S
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of action levels in imaging strategies in head and neck cancer using TomoTherapy. Are our margins adequate in the absence of image guidance?
    Houghton F; Benson RJ; Tudor GS; Fairfoul J; Gemmill J; Dean JC; Routsis DS; Jefferies SJ; Burnet NG
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):720-7. PubMed ID: 19740637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6 mm in head and neck squamous cell carcinoma: Significant acute and late toxicity reduction.
    Al-Mamgani A; Kessels R; Janssen T; Navran A; van Beek S; Carbaat C; Schreuder WH; Sonke JJ; Marijnen CAM
    Radiother Oncol; 2022 Mar; 168():16-22. PubMed ID: 35065998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience.
    Peeken JC; Knie C; Kessel KA; Habermehl D; Kampfer S; Dapper H; Devecka M; von Eisenhart-Rothe R; Specht K; Weichert W; Wörtler K; Knebel C; Wilkens JJ; Combs SE
    Radiat Oncol; 2019 Jan; 14(1):2. PubMed ID: 30626408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-guided radiotherapy for head and neck cancer: initial clinical experience.
    Chen AM; Hsu S; Lamb J; Yang Y; Agazaryan N; Steinberg ML; Low DA; Cao M
    Clin Transl Oncol; 2018 Feb; 20(2):160-168. PubMed ID: 28612199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of daily versus nondaily image-guided radiotherapy protocols for patients treated with intensity-modulated radiotherapy for head and neck cancer.
    Yu Y; Michaud AL; Sreeraman R; Liu T; Purdy JA; Chen AM
    Head Neck; 2014 Jul; 36(7):992-7. PubMed ID: 23780718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
    Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
    Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.